A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017.

Boston Cell- and Tissue-Based Therapy / methods Humans Induced Pluripotent Stem Cells / cytology International Cooperation Pluripotent Stem Cells / cytology Quality Control Stem Cells / cytology Tissue Banks / standards
Banking Global harmonization International Stem Cell Banking Initiative Pluripotent stem cells Quality controls

Journal

Stem cells (Dayton, Ohio)
ISSN: 1549-4918
Titre abrégé: Stem Cells
Pays: England
ID NLM: 9304532

Informations de publication

Date de publication:
09 2019
Historique:
received: 28 11 2018
revised: 07 01 2019
accepted: 10 01 2019
pubmed: 26 4 2019
medline: 1 7 2020
entrez: 26 4 2019
Statut: ppublish

Résumé

This report summarizes the recent activity of the International Stem Cell Banking Initiative held at Harvard Stem Cell Institute, Boston, MA, USA, on June 18, 2017. In this meeting, we aimed to find consensus on ongoing issues of quality control (QC), safety, and efficacy of human pluripotent stem cell banks and their derivative cell therapy products for the global harmonization. In particular, assays for the QC testing such as pluripotency assays test and general QC testing criteria were intensively discussed. Moreover, the recent activities of global stem cell banking centers and the regulatory bodies were briefly summarized to provide an overview on global developments and issues. Stem Cells 2019;37:1130-1135.

Identifiants

DOI: 10.1002/stem.3003 PMID: 31021472 PMC: PMC7187460
pubmed: 31021472
doi: 10.1002/stem.3003
pmc: PMC7187460
doi:

Types de publication

Congress Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1130-1135

Subventions

Organisme : BBSRC
Pays : International
Organisme : MRC
Pays : International

Informations de copyright

©2019 The Authors. Stem Cells published by Wiley Periodicals, Inc. on behalf of AlphaMed Press 2019.

Références

Stem Cell Reports. 2017 Jul 11;9(1):1-4
pubmed: 28700896
Regen Med. 2015;10(2 Suppl):1-44
pubmed: 25675265
Stem Cells Transl Med. 2017 Nov;6(11):1956-1962
pubmed: 29067781
Nat Commun. 2018 May 15;9(1):1925
pubmed: 29765017
Nat Biotechnol. 2007 Jul;25(7):803-16
pubmed: 17572666
Curr Stem Cell Rep. 2015;1(2):110-117
pubmed: 26225325
Cell. 2016 May 5;165(4):1002-11
pubmed: 27114037
ALTEX. 2017;34(1):95-132
pubmed: 27554434

Auteurs

Jung-Hyun Kim (JH)

Division of Intractable Diseases, Korea National Stem Cell Bank, Center for Biomedical Sciences, Korea National Institute of Health, Cheongju, Korea.
ORCID: 0000-0002-9496-9474

Alex Alderton (A)

Wellcome Sanger Institute, Cambridge, United Kingdom.

Jeremy M Crook (JM)

ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, University of Wollongong, Wollongong, Australia.
Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, Australia.
Department of Surgery, St Vincent's Hospital, The University of Melbourne, Melbourne, Australia.

Nissim Benvenisty (N)

The Azrieli Center for Stem Cells and Genetic Research, Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel.

Catharina Brandsten (C)

Takara Bio Europe AB, Göteborg, Sweden.

Meri Firpo (M)

Cell Line Development Memphis Meats, Berkeley, California, USA.
University of Minnesota, Minneapolis, Minnesota, USA.

Peter W Harrison (PW)

European Bioinformatics Institute (EMBL-EBI), Cambridge, United Kingdom.

Shin Kawamata (S)

Foundation for Biological Research and Innovation (FBRI), Kobe, Japan.

Eihachiro Kawase (E)

Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.

Andreas Kurtz (A)

Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Jeanne F Loring (JF)

Center for Regenerative Medicine, Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA.

Tenneille Ludwig (T)

WiCell Research Institute, WiCell Stem Cell Bank, Madison, Wisconsin, USA.

Jennifer Man (J)

UK Stem Cell Bank, National Institute for Biological Standards and Control, South Mimms, United Kingdom.
Adaptimmune Ltd., Abingdon, United Kingdom.

Joanne C Mountford (JC)

Advanced Therapeutics, Scottish National Blood Transfusion Service, Edinburgh, United Kingdom.

Marc L Turner (ML)

Advanced Therapeutics, Scottish National Blood Transfusion Service, Edinburgh, United Kingdom.
Cell & Gene Therapy Catapult, Guy's Hospital, London, United Kingdom.
The Jack Copland Centre, Global Alliance for iPSC Therapies (GAiT), Edinburgh, United Kingdom.

Steve Oh (S)

National Laboratory for Embryonic Stem Cells (LaNCE), Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo, São Paulo, Brazil.

Lygia da Veiga Pereira (L)

Hematology and Stem Cell Laboratory, Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul. Stem Cell Research Institute, Porto Alegre, Brazil.
ORCID: 0000-0002-0002-725X

Patricia Pranke (P)

Department of Genetics, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.

Michael Sheldon (M)

Roslin Innovation Centre, Censo Biotechnologies Ltd, Midlothian, United Kingdom.

Rachel Steeg (R)

Stem Cell Group, Bioprocessing Technology Institute, Singapore, Singapore.

Stephen Sullivan (S)

The Jack Copland Centre, Global Alliance for iPSC Therapies (GAiT), Edinburgh, United Kingdom.

Michael Yaffe (M)

New York Stem Cell Foundation, New York, New York, USA.

Qi Zhou (Q)

State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, People's Republic of China.

Glyn N Stacey (GN)

International Stem Cell Banking Initiative, Royston, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Villes › Boston › A Report from a Workshop of the International...
questionsmedicales.fr › Thérapeutique › Biothérapie › Thérapie cellulaire et tissulaire › A Report from a Workshop of the International...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A Report from a Workshop of the International...
questionsmedicales.fr › Cellules › Cellules souches › Cellules souches pluripotentes › Cellules souches pluripotentes induites › A Report from a Workshop of the International...
questionsmedicales.fr › Sciences sociales › Internationalité › Coopération internationale › A Report from a Workshop of the International...
questionsmedicales.fr › Cellules › Cellules souches › Cellules souches pluripotentes › A Report from a Workshop of the International...
questionsmedicales.fr › Technologie, industrie et agriculture › Technologie › Contrôle de qualité › A Report from a Workshop of the International...
questionsmedicales.fr › Cellules › Cellules souches › A Report from a Workshop of the International...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Biobanques › Banques de tissus › A Report from a Workshop of the International...